Back to search

Michigan Technological University

VIRUS-LIKE PARTICLE VACCINE MANUFACTURING FROM YEAST

Abstract

dc:description.abstract

Influenza virus has an intrinsic nature to undergo mutations. Hence, there have been struggles to combat this disease since the time when the worst influenza pandemic first hit in 1918. Vaccines have proved to be effective in controlling the spread of the influenza A virus by providing herd immunity. However, the contemporary design of influenza A virus based on egg and cell-culture is not efficient in tackling influenza A virus transformation. Virus-like particles (VLPs) have established themselves as a potental platform for future vaccine candidates. VLPs have all the credentials to supplant contemporary vaccine designs without compromising on immunogenicity. For expression of VLPs, yeast has all the definitive potential to develop new-generation influenza A vaccines. This report describes how to use Hansenula polymorpha, a yeast, to make VLPs of influenza H1N1 virus.

Degree

thesis:*
Name thesis:degree_name
Master of Science in Chemical Engineering (MS)
Level thesis:degree_level
Open Access Master's Report
Discipline thesis:degree_discipline
Department of Chemical Engineering

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Ananya, Ananya
Committee members dc:contributor.committeemember
  • Rebecca Ong
  • Timothy Eisele
Contributors dc:contributor
  • Caryn Heldt

Subjects

dc:subject × 1

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Michigan Technological University
Base URL
digitalcommons.mtu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Ananya, Ananya. VIRUS-LIKE PARTICLE VACCINE MANUFACTURING FROM YEAST. Open Access Master's Report thesis, https://doi.org/10.37099/mtu.dc.etdr/1065